Efficacy of Neoadjuvant Chemotherapy on Nephron-Sparing Surgery for Wilms Tumor in Horseshoe Kidney
Topic overview
This commentary addresses surgical decision-making for Wilms tumor in horseshoe kidney, emphasizing that nephron-sparing approaches must preserve >50% of renal parenchyma to avoid functional equivalent of nephrectomy. The authors contribute to ongoing discussion about standardizing feasibility criteria for partial nephrectomy in this anatomic variant.
Key takeaways
- Nephron-sparing surgery for Wilms tumor in horseshoe kidney requires >50% parenchymal preservation to avoid functional unilateral nephrectomy.
- Removing one renal moiety plus isthmus in horseshoe kidney is functionally equivalent to complete nephrectomy in normal two-kidney anatomy.
- Standardized feasibility criteria are needed to guide nephron-sparing approaches in horseshoe kidney Wilms tumor cases.
- Anatomic considerations in horseshoe kidney demand higher preservation thresholds than conventional partial nephrectomy for Wilms tumor.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Efficacy of Neoadjuvant Chemotherapy on Nephron-Sparing Surgery for Wilms Tumor in Horseshoe Kidney. GlobalCastMD Medical Library. 2024-04-12. https://dev.library.globalcastmd.com/article/8508?via_space=staycurrentmd
Comments